CUE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Cue Biopharma Inc (CUE) is not a good buy for a beginner investor with a long-term strategy at this time. The stock shows weak financial performance, no significant positive catalysts, and lacks strong trading signals or institutional interest. Given the user's preference for long-term investment, it's better to wait for clearer signs of growth or stability before considering this stock.
The stock's MACD is slightly positive but contracting, RSI is neutral at 44.41, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 0.286, with resistance at 0.305 and support at 0.268. Overall, the technical indicators suggest a weak and uncertain trend.
NULL. There are no recent news events, no significant insider or hedge fund activity, and no recent congress trading data.
Additionally, there is no recent analyst activity or valuation data to support a positive outlook.
In Q3 2025, revenue dropped to $2,149,000 (-35.58% YoY), net income dropped to -$7,448,000 (-14.00% YoY), and EPS dropped to -0.07 (-58.82% YoY). Gross margin remained stable at 100%. Overall, the financials indicate poor growth and profitability trends.
No recent analyst ratings or price target updates are available for Cue Biopharma Inc.
